Search PubMed⌕ Search

Biomedical subjects

J B Marsh

Publications and source records attributed to J B Marsh.

At least 37 records · Page 2Linked to original sources

Characterization of nascent high density lipoprotein subfractions from perfusates of rat liver.

Nascent high density lipoprotein (HDL) (1.063 less than d less than 1.21 g/ml) was isolated from recirculating rat liver perfusates and separated by heparin-Sepharose chromatography into a nonretained fraction (NR) and a fraction (R) that eluted with 0.5 M NaCl. Fractions NR and R contained 70% and 30% of the nascent HDL protein, respectively. ApoB-containing particles were removed from fraction R by chromatography on concanavalin A. The protein composition of fractions NR and R was 40% and 29%, respectively. Fraction NR contained 25% apoA-I, 11% apoA-IV, 24% apoE, and 38% apoC. Fraction R contained primarily apoE (81% of total protein). The lipid composition of NR and R, respectively, was: triglyceride 44% and 26%, phospholipid 41% and 57%, cholesterol 8% and 13%, and cholesteryl ester 7% and 4%. Fractions NR and R had molecular weights of 400,000 and 860,000, respectively, as calculated from the Stokes radius. Negative staining electron microscopy indicated that both fractions consisted mainly of spherical particles (260-280 A) but some stacked disks were seen in fraction R. Livers perfused by the single-pass technique produced fractions NR and R in the same ratio as livers perfused by recirculation. The apolipoprotein compositions were similar to those in the recirculating perfusion; however, both fractions NR and R had more triglyceride (greater than 50% of total lipid). An HDL fraction was also isolated from liver perfusates by a combination of molecular sieve and heparin-Sepharose affinity chromatography. This HDL contained triglyceride but no apoB, indicating that triglyceride-rich HDL particles are not an artifact of ultracentrifugation.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Metabolism of triglyceride-rich nascent rat hepatic high density lipoproteins.

Nascent high density lipoprotein (HDL) and nascent very low density lipoprotein (VLDL) were isolated from rat livers that had been perfused with [3H]glycerol to label the triglyceride. When injected into intact rats, the labeled HDL-triglyceride disappeared as rapidly as the VLDL-triglyceride, with only 10% of the injected label remaining in the plasma after 30 min. The protein moiety of nascent HDL was labeled with [35S]methionine in a similar fashion and the labeled nascent HDL was separated into nonretained (NR) and retained (R) fractions by heparin-Sepharose affinity chromatography. When injected into rats, 55% of the injected label in nascent fraction NR and 72% of that in nascent fraction R was recovered from plasma at 30 min, compared to only 10% of the triglyceride label from unfractionated nascent HDL, indicating dissociation of triglyceride and apolipoprotein clearance. The plasma decay curves for both triglyceride and protein were biexponential. By 5 min, 15% of the 35S label remaining in plasma represented apoE and apoC that had been transferred from nascent HDL fractions NR and R to the d less than 1.063 g/ml fraction of plasma. Plasma HDL was labeled in vivo with [35S]methionine, separated into fractions NR and R, and the clearance of the two plasma HDL fractions was compared with that of the corresponding nascent HDL fractions. Except for a faster rate of removal of the nascent HDL fractions during the first 5 min, the serum decay curves were very similar.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Ascites fluid lipoproteins in experimental nephrotic syndrome.

Lipoprotein content and composition were studied in ascites fluid of puromycin aminonucleoside-nephrotic rats. All of the lipoprotein density classes were found in ascites fluid. Protein levels compared to plasma were: very low density lipoprotein (VLDL, d less than 1.006), 1.2%; intermediate density lipoprotein (IDL, 1.006 less than d less than 1.02), 2.6%; low density lipoprotein (LDL, 1.02 less than d less than 1.063), 1.0%; and high density lipoprotein (HDL, 1.063 less than d less than 1.21), 1.1%. The predominant protein in ascites fluid was albumin, present at 1.9% of the plasma level. Radioiodinated VLDL and HDL injected intravenously into nephrotic rats appeared in lipoprotein fractions of the ascites fluid. VLDL and IDL triacylglycerol content and particle diameter were low compared with plasma particles, suggesting peritoneal triacylglycerol lipase activity; such lipase activity could account for the increased proportion of LDL in the ascites fluid. Ascites fluid LDL and HDL phospholipid and free cholesterol were high and cholesteryl ester was low. Ascites lipoproteins contained the same apolipoproteins as plasma, but in different proportions. Ascites VLDL had higher apolipoprotein B and lower apolipoprotein E, while LDL and HDL had higher apolipoprotein E. Ascites HDL could be separated by heparin-Sepharose affinity column chromatography into a retained and a non-retained fraction, while nearly all nephrotic plasma HDL was non-retained. These data suggest that modification of ascites fluid lipoproteins occurs prior to their entry into the lymph and return to the blood, perhaps mediated by peritoneal macrophages.

Animals↗

Inhibition of apolipoprotein secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat liver.

Infusion of albumin-bound eicosapentaenoic acid (EPA) docosahexaenoic acid (DHA), or oleic acid (OA) in perfused rat livers was carried out for two hours at a rate that maintained the perfusate concentration at 1 mmol/L. When compared with fatty acid-poor albumin alone, triacylglycerol (TAG) output was not significantly increased with DHA or EPA, whereas OA infusion resulted in a twofold increase. Incorporation of labeled leucine into VLDL apo B-100, apo B-48, apo E, and apo Cs was decreased by 50% by DHA or EPA compared with OA. The total phosphatidate phosphohydrolase activity was decreased by 35% with DHA or EPA compared to oleic acid or albumin alone. In no case was there a significant change in the distribution of activity between the microsomal and cytosolic factions. Fatty acid infusion did not significantly change the liver TAG content. Total liver lipids, microsomal lipids, and lipids of secreted VLDL were enriched with the infused fatty acids. The degree of enrichment for secreted TAG averaged 24% for OA and 36% for DHA or EPA. The effects of DHA and EPA on PPH activity and on apo B secretion in feeding experiments with marine oils rich in these acids may relate to changes in the fatty acid composition of liver membranes.

Animals↗

Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat.

In rats fed a fish oil-enriched diet, plasma triacylglycerols were lowered 51%. At the same time there was a mean 45% reduction in Mg2+-dependent phosphatidate phosphohydrolase activity in liver microsomes and a mean 20% decrease in microsomal triacylglycerol (neutral) and diacylglycerol hydrolase activities, but not of diacylglycerol acyltransferase. These observations support the hypothesis that decreases in the activities of phosphatidate phosphohydrolase and of both lipases are involved in the expression of the inhibitory effects of fish oil feeding on hepatic lipoprotein triacylglycerol secretion. Conversely, the feeding of a sucrose-enriched diet resulted in a mean 39% rise in plasma triacylglycerols, a 19% increase in triacylglycerol hydrolase and a mean 45% increase in Mg2+-dependent microsomal phosphohydrolase activity. The effects of the two nutritional interventions on phosphatidate phosphohydrolase activity confirm a key function for this enzyme in triacylglycerol formation.

Acyltransferases↗

High density lipoprotein binding by rat Fu5AH hepatoma cells is not related to cholesterol content.

The binding of 125I-HDL obtained from nephrotic rats (HDLne) containing only apo A-I and apo C, to rat hepatoma cells (Fu5AH) grown to confluency was studied under conditions which increased the free cholesterol or the cholesteryl ester content. The high affinity binding (Kd = 5 nM) measured at 4 degrees C was unchanged. This transformed cell line also exhibited greater specificity for rat HDL compared to human HDL than has been reported for other types of cultured cells. When the cells were allowed to internalize and degrade HDLne at 37 degrees C, the acid-soluble products were derived almost entirely from the breakdown of apo A-I. Competition experiments with an LDL fraction from nephrotic rat plasma (LDLne) which contained 20% of apo A-I indicated that it was as effective as other rat HDL preparations in competing for the binding of HDLne at 4 degrees C, based on its content of apo A-I. Control experiments indicated that labeled apo A-I in HDLne exchanged less than 1% when incubated with a 50-fold excess of unlabeled LDLne for 2 h at 4 degrees C. These results point to a critical role of cell type in HDL binding. They support the view that apo A-I is a ligand. The up-regulation of high affinity HDL binding by cholesterol which has been reported with cultured human fibroblasts and Hep G2 cells does not occur in the Fu5AH rat hepatoma cell line.

Animals↗

Hepatic lipoprotein biosynthesis.

Methods for the study of hepatic lipoprotein synthesis and secretion have been described, and the advantages of each system discussed. Attention has been focused on intact cell systems. The isolated perfused liver constitutes a standard of comparison for all others, even though it, too, has limitations. Table IV below gives our assessment of some of the advantages and disadvantages of the techniques for studying hepatic lipoprotein biosynthesis.

Animals↗

Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry.

Stable isotope methodology has been adapted to the study of lipoprotein turnover in human subjects. Using endogenous [15N]glycine labeling and gas-liquid chromatographic-mass spectrometric analysis, synthesis of apolipoprotein B in very low density lipoprotein (VLDL) was measured directly in five normal and two hyperlipidemic subjects. An isotopic precursor steady state was achieved during the studies by utilizing a priming dose and constant infusion containing [15N]glycine. Measurement of the plateau in 15N enrichment in the urinary hippurate produced during each study was used to estimate the 15N enrichment of the hepatic glycine precursor pool. The range of values for the fractional synthetic rate of VLDL apoB in the normal subjects obtained by this method was 5.9 to 11.5 day-1, with a mean of 9.2 +/- 2.4 (SD). This value agrees with the results of previous investigations which have utilized other methods. The method was also tested in two hypertriglyceridemic subjects and gave fractional synthetic rates of VLDL apoB that were significantly lower than in normals (1.5 and 2.8 day-1). This stable isotope method allows calculation of the fractional synthetic rate of VLDL apoB by maintaining an isotopic steady state throughout the study. It makes possible repeated studies in the same individual since no risk of exposure to radioisotopes is involved.

Apolipoproteins B↗

Catabolism of very low density lipoproteins in experimental nephrosis.

The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.

Animals↗

Metabolism of two forms of apolipoprotein B of VLDL by rat liver.

Apolipoprotein B (apoB) is composed of metabolically distinct fractions of higher molecular weight (apoBh) and lower molecular weight (apoBl). When 125I-labeled very low density lipoprotein (VLDL) prepared from recirculating liver perfusates was injected into rats, labeled apoBl was preferentially removed from the plasma and apoBh entered low density lipoprotein (LDL). The time-related movement of labeled apoBh into higher density fractions was independent of that of labeled apoBl. When 125I-labeled triglyceride-rich lipoprotein (TRL) prepared from sucrose-fed rats was incubated with plasma from rats injected with heparin and then studied in a recirculating liver perfusion, apoBl was preferentially removed compared to apoBh. Thus, the loss of apoBl of hepatic VLDL in vivo was similar to the loss of apoBl of lipase-treated TRL in vitro. In control perfusions where TRL was incubated with heat-treated postheparin plasma, not only was there less initial hepatic clearance of apoB but the early phase of preferential apoBl removal during 30 min of perfusion was not observed. ApoE removal from perfusates was the same whether or not the TRL had been treated with heparin-releasable lipases. Apoprotein degradation, as indicated by the appearance in the perfusate of labeled degradation products, occurred 30 min after the preferential phase of apoBl removal. These results suggest that hepatic clearance of VLDL and TRL remnants is favored by lipolysis and by the presence of apoBl on the particle that enhances their hepatic binding and degradation.

Animals↗

Catabolism of the apolipoproteins of HDL in control and nephrotic rats.

125I-labeled high density lipoprotein (HDL) from control rats, or from rats made nephrotic by puromycin aminonucleoside, was injected into control or nephrotic rats. At 5 and 20 h, the amount and distribution of label remaining in apolipoproteins HDL, A-I, E, A-IV and the C apolipoproteins was measured after ultracentrifugal isolation of HDL and SDS-polyacrylamide gel electrophoretic separation of each apolipoprotein. There were no significant differences in the removal rates of apolipoprotein HDL or of the individual apolipoproteins when the removal of HDL of controls was compared to HDL of nephrotics. HDL from nephrotic rats contains less than 10% of either the apolipoprotein A-IV or apolipoprotein E content of control HDL, indicating that neither apolipoprotein A-IV nor apolipoprotein E play a significant role in determining the catabolic fate of rat HDL. In severely nephrotic animals the apoliprotein C content of HDL was reduced to 50% of control values and the apolipoprotein A-I content of HDL rose to 87% of the total apolipoprotein. The individual apolipoproteins of HDL from either nephrotics or controls were catabolized at the same rates irrespective of the degrees of nephrosis or altered HDL apolipoprotein composition. The apparent fractional catabolic rates for apolipoprotein HDL and for each of the apolipoproteins, determined after 20 h, did not differ from one another, and all were reduced by half in the nephrotic rats compared to the normal controls. These results support the concept that HDL is catabolized as a particle mediated by apolipoprotein A-I recognition, and they reinforce earlier work indicating that increased synthesis is the dominant factor responsible for increased plasma HDL concentrations in experimental nephrosis.

Animals↗

Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat.

The in vivo incorporation of labeled amino acids into two forms of apolipoprotein B of nascent hepatic, nascent intestinal, and plasma lipoproteins was studied. Using SDS-gel filtration column chromatography rat apolipoprotein B was separated into two proteins of higher (apo Bh) and of lower (apo Bl) molecular size and the incorporation of label into each was measured. When livers isolated from fed rats were perfused with 3H-labeled amino acids, radioactivity was incorporated into both forms of apo B of the d less than 1.060 fractions (very low (VLDL), intermediate (IDL), and low (LDL) density lipoproteins) with a labeling ratio of apo Bl to apo Bh of 0.8. When mesenteric lymph was collected from corn oil fed rats intraduodenally injected with 3H-labeled amino acids, radioactivity was mainly incorporated into apo Bl of chylomicrons and VLDL with apo Bl to apo Bh labeling ratios of 14 and 44, respectively. Plasma was isolated 2 h after intraperitoneal injection of 3H-labeled amino acids into chow fed rats and lipoproteins were isolated by sequential density ultracentrifugation. The labeling ratio of apo Bl and apo Bh decreased from 4.2 in VLDL to 0.5 in LDL indicating a progressive enrichment of apo Bh in the LDL fraction. High density lipoproteins (HDL) contained less than 4% of the total labeled apo B and was enriched in apo Bl. The results of this study indicate that the liver synthesizes both forms of apo B while the intestine synthesizes almost entirely apo Bl. Since both apo B proteins are secreted primarily by the liver into VLDL, the results are consistent with preferential removal of apo Bl during triglyceride-rich lipoprotein catabolism and entry of hepatically derived apo Bh into LDL.

Animals↗

Analysis of lipoprotein apoproteins by SDS-gel filtration column chromatography.

Rat plasma, containing 125I-labeled triglyceride-rich lipoprotein, was mixed following lipid extraction with 10% SDS buffer and analyzed by gel filtration chromatography on columns using an elution buffer containing 1% SDS. Labeled apoproteins were separated into apo B, apo E, and apo C radioactivity peaks. Labeled peptides, tyrosine, and iodide were also resolved by this method. Isolated lipoprotein fractions were separated into the same components. The method offers the advantages of quantitative radioactivity recovery, large sample volume, and resolution of two apo B proteins.

Amino Acids↗